Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
Programme I -

Programme EHDN 2014

Thursday, September 18th, 2014

16:00-22:00   Registration Desk

Friday, September 19th, 2014
07:30-08:30   Registration Desk
 
Welcome and Introduction
08:30-09:00 G. Bernhard Landwehrmeyer (Ulm, Germany)
Bea De Schepper (President of the EHA, Moerbeke-Waas, Belgium)
 
Plenary Session I:
'The Natural History Of HD'
Chair: Sarah Tabrizi (London, UK)
Co-chair: Ray Dorsey (Baltimore, USA)
 
09:00-09:20   Natural history of HD in human
Sarah Tabrizi (London, UK)
 
09:20-09:40   Natural history in animal models of HD: HD recapitulation?
Roger Barker (Cambridge, UK)
 
09:40-10:00   Enroll HD: an update on progress and future development
G. Bernhard Landwehrmeyer (Ulm, Germany)
 
10:00-10:30   Panel discussion
Ray Dorsey (Baltimore, USA)
 
10:30-11:00   Tea/Coffee Break

Plenary Session II:
'Disease Modifiers'

Chair: Lesley Jones (Cardiff, UK)
Co-chair: James Gusella (Boston, USA)
 
11:00-11:20   Genetic modifiers
Lesley Jones (Cardiff, UK)
 
11:20-11:40   Environmental modifiers
Jan Frich (Oslo, Norway)
 
11:40-12:00   Modifiers: an opportunity to test in clinical trials?
Jose Florez (Massachusetts, USA)
 
12:00-12:30   Panel discussion
 
Poster Viewing
Chairs: TBA
 
12:30-14:00   Poster Viewing & Poster Tours
 
12:30-14:00   Buffet Style Lunch
 
Parallel Session I:

Science Session:
'Targeting KMO'
Chair: Flaviano Giorgini (Leicester, UK)
Co-Chair: Cheryl Fitzer-Attas (Princeton, USA)
 
14:00-14:15   Basic understanding and gaps
Ladislav Mrzljak (Princeton, USA)
 
14:15-14:30   KMO: markers and drug development
Leticia Toledo-Sherman (Los Angeles, USA)
 
14:30-14:45   Clinical trials in perspective
Cristina Sampaio (Princeton, USA)
 
14:45-15:00   Panel discussion
 
Clinical Practice Session:
'HD diagnosis'
Chair: Alexandra Dürr (Paris, France)
Co-Chair: Karen Anderson (Baltimore, USA)
 
14:00-14:15   Genetic testing in pre-symptomatic HD
Alexandra Dürr (Paris, France)
 
14:15-14:30   Should diagnostic criteria in HD be changed?
Elizabeth McCusker (Sydney, Australia)
 
14:30-14:45   Is there a need for regular check-ups?
David Craufurd (Manchester, UK)
 
14:45-15:00   Panel discussion
 
Short Communications I:
'Scientific Presentations: 10’ and 5’ questions – selected from submissions'

Chair: Jaime Kulisevsky (Barcelona, Spain)
 
15:15-15:30   TBA
TBA
 
15:30-15:45   TBA
TBA
 
15:45-16:00   TBA
TBA
 
16:00-16:15   TBA
TBA
 
16:15-16:45   Tea/Coffee Break
 
Plenary Session III:
'Biomarkers'

Chair: Rachael Scahill (London, UK)
Co-chair: Andrew Feigin (New York, USA)
 
16:45-17:05   Reviewing progress to date in HD
Blair Leavitt (Vancouver, Canada)
 
17:05-17:25   A look at the road ahead - The challenge of biomarkers and the endpoints quest
Beth Borowsky (Princeton, USA)
 
17:25-17:45   Panel discussion
 
Roundup I: Lessons of the day
17:45-18:00   Lessons of the day
Edward Wild (London, UK) and Jeff Carroll (Bellingham, USA)
 
Evening get together
18:15-20:15   
Guided Poster Tour
 
18:30-20:00   
Meet Experts around tapas and wine
Experts and Topics TBA
 
18:30-19:45
Film - Do you really want to know
Film - Alive and Well
 
20:15-21:30 Film - Alive and Well
Film - Do you really want to know